You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The UCSF Viral Diagnostics and Discovery Center will use sequencing, microarrays, and other genomic technologies to characterize pathogens linked to acute and chronic human illnesses.
The suit revolves around patents owned by UNeMed, the technology-transfer organization for the UN Medical Center, and exclusively licensed to Abbot Laboratories, though Abbott is not listed as a co-plaintiff on the complaint.
The California District court denied motions for summary judgment of invalidity of Abbott's in situ DNA hybridization patent.
LGC will develop clinical and non-clinical applications for the Ibis T5000 Biosensor System.
Epigenomics, Response Genetics, Exact Sciences
Kevin Ulmer, Patrick Soon-Shiong, Shaun Lonergan
William Moffitt signed a three-year contract to remain president and CEO of Nanosphere, while BioTrove's Al Luderer joined Agendia's supervisory board, and more.
Mort Minaee, Jay Flatley, Mari Baker
A German shepherd called Nala has had her genome sequenced.
A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?
Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.
In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.